✦ LIBER ✦

P606 Once-daily versus three-times-daily oral budesonide in active Crohn's disease: a double-blind, double-dummy, randomized trial

✍ Scribed by Dignass, A.; Grinevich, V.; Zakharash, M.; Goldis, A.; Jonaitis, L.; Gabalec, L.; Vasileva, G.; Rácz, I.; Pekárková, B.; Derova, J.; Greinwald, R.; Mueller, R.

Book ID: 122466337
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 97 KB
Volume: 7
Category: Article
ISSN: 1873-9946
DOI: 10.1016/S1873-9946(13)60627-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once versus three times daily dosing of

Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial

✍ Dignass, Axel; Stoynov, Simeon; Dorofeyev, Andrey E.; Grigorieva, Galina A.; Tom 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 706 KB

Sa1217 Once Daily Dosing of 9mg Budesoni

Sa1217 Once Daily Dosing of 9mg Budesonide (Budenofalk®) Is Therapeutic Equivalent to a Three-Times Daily Dosing of 3mg Budesonide for the Treatment of Active Crohn's Disease: A Randomized, Double-Blind, Double-Dummy, Multicenter Phase III Study

✍ Dignass, Axel U.; Stoynov, Simeon; Dorofeyev, Andrey E.; Grigorieva, Galina A.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 414 KB

83 Efficacy and Tolerability of a Once D

83 Efficacy and Tolerability of a Once Daily Treatment with Budesonide Capsules Versus Mesalamine Granules for the Treatment of Active Ulcerative Colitis: A Randomized, Double-Blind, Double-Dummy, Multicenter Study

✍ Volker Gross; Ivan Bunganic; Tatyana L. Mikhailova; Limas Kupcinskas; Gediminas 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Once, twice, or three times daily famcic

Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial

✍ Stephen D. Shafran; Stephen K. Tyring; Richard Ashton; Jacque Decroix; Chistine 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 76 KB

P4-405: A multinational, randomized, dou

P4-405: A multinational, randomized, double-blind, placebo-controlled, parallel-group trial of memantine extended-release capsule (28 mg, once daily) in patients with moderate to severe Alzheimer's disease

✍ Grossberg, George; Manes, Facundo; Allegri, Ricardo; Gutierrez Robledo, Luis Mig 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB